TP53 and cancer: A previous study on the association of the TP53 polymorphism with the development of cancer in Indians reported that the mean frequencies of the GG, CG, and CC genotypes in controls were 33.1% (range, 14.4%–80.6%), 46.8% (range, 15.1%–65.4%), and 20.1% (range, 4.3%–38.5%), respectively (Mandal et al., 2014).